296 related articles for article (PubMed ID: 8544772)
1. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
[TBL] [Abstract][Full Text] [Related]
2. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.
Castelo-Branco C; Martínez de Osaba MJ; Pons F; Fortuny A
Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
[TBL] [Abstract][Full Text] [Related]
5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
6. Menstrual history as a determinant of current bone density in young hirsute women.
Castelo-Branco C; Pons F; Martinez de Osaba MJ; Garrido J; Fortuny A
Metabolism; 1996 Apr; 45(4):515-8. PubMed ID: 8609841
[TBL] [Abstract][Full Text] [Related]
7. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
8. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
Ruutiainen K; Erkkola R; Kaihola HL; Santti R; Irjala K
Acta Obstet Gynecol Scand; 1985; 64(8):629-33. PubMed ID: 2938400
[TBL] [Abstract][Full Text] [Related]
9. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and clinical effects of ketoconazole in hirsute women.
Martikainen H; Heikkinen J; Ruokonen A; Kauppila A
J Clin Endocrinol Metab; 1988 May; 66(5):987-91. PubMed ID: 2966183
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
[TBL] [Abstract][Full Text] [Related]
12. Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy.
Isojärvi JI
Epilepsia; 1990; 31(4):438-45. PubMed ID: 2142450
[TBL] [Abstract][Full Text] [Related]
13. Effects of carbamazepine on the hypothalamic-pituitary-gonadal axis in male patients with epilepsy: a prospective study.
Isojärvi JI; Pakarinen AJ; Myllylä VV
Epilepsia; 1989; 30(4):446-52. PubMed ID: 2526730
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
15. [Defects of adrenal steroidogenesis in patients with hirsutism].
Salinas Vert I; Audí Parera L; Granada Ybern ML; Lucas Martín A; Pizarro Lozano E; Foz Sala M; Sanmartí Sala A
Med Clin (Barc); 1998 Feb; 110(5):171-6. PubMed ID: 9547720
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of routine gonadotropin and androgen measurements in hirsute women.
Helfer EL; Miller JL; Rose LI
Am J Med Sci; 1990 Feb; 299(2):94-7. PubMed ID: 2137289
[TBL] [Abstract][Full Text] [Related]
17. The pituitary-gonadal axis in women with benign or malignant ovarian tumors.
Blaakaer J; Djursing H; Hørding U; Bennett P; Toftager-Larsen K; Bock JE; Lebech PE
Acta Endocrinol (Copenh); 1992 Aug; 127(2):127-30. PubMed ID: 1388313
[TBL] [Abstract][Full Text] [Related]
18. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
Medina M; Herrera J; Flores M; Martin O; Bermúdez JA; Zárate A
Fertil Steril; 1986 Dec; 46(6):1021-5. PubMed ID: 3023147
[TBL] [Abstract][Full Text] [Related]
19. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
[TBL] [Abstract][Full Text] [Related]
20. Clinical and endocrine effects of flutamide in hyperandrogenic women.
Fruzzetti F; De Lorenzo D; Ricci C; Fioretti P
Fertil Steril; 1993 Nov; 60(5):806-13. PubMed ID: 8224265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
